lestaurtinib has been researched along with gw 2580 in 1 studies
| Studies (lestaurtinib) | Trials (lestaurtinib) | Recent Studies (post-2010) (lestaurtinib) | Studies (gw 2580) | Trials (gw 2580) | Recent Studies (post-2010) (gw 2580) |
|---|---|---|---|---|---|
| 124 | 12 | 63 | 48 | 0 | 40 |
| Protein | Taxonomy | lestaurtinib (IC50) | gw 2580 (IC50) |
|---|---|---|---|
| Chain A, BDNF/NT-3 GROWTH FACTORS RECEPTOR | Homo sapiens (human) | 0.038 | |
| Chain A, BDNF/NT-3 GROWTH FACTORS RECEPTOR | Homo sapiens (human) | 0.038 | |
| Chain A, BDNF/NT-3 GROWTH FACTORS RECEPTOR | Homo sapiens (human) | 0.038 | |
| High affinity nerve growth factor receptor | Homo sapiens (human) | 0.88 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.003 | |
| Macrophage colony-stimulating factor 1 receptor | Homo sapiens (human) | 0.1947 | |
| Macrophage colony-stimulating factor 1 receptor | Mus musculus (house mouse) | 0.392 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ciceri, P; Davis, MI; Herrgard, S; Hocker, M; Hunt, JP; Pallares, G; Treiber, DK; Wodicka, LM; Zarrinkar, PP | 1 |
1 other study(ies) available for lestaurtinib and gw 2580
| Article | Year |
|---|---|
Comprehensive analysis of kinase inhibitor selectivity.
Topics: Catalysis; Drug Design; Enzyme Stability; High-Throughput Screening Assays; Humans; Protein Binding; Protein Kinase Inhibitors; Protein Kinases; Proteomics; Signal Transduction; Substrate Specificity | 2011 |